Brandon D. Gallas

Dr. Brandon D. Gallas

United States Food and Drug Administration, Silver Spring, Maryland, USA
orcid

Research Focus & Metrics

Academic Career Length

29Years (1998-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 January 2010 in Breast Cancer Research
Verified
Journal Article
Open access
PDF file
Vlad PopoviciVlad Popovici
Vlad Popovici
WCWeijie Chen
Weijie Chen
BGBrandon D. Gallas
Brandon D. Gallas
CHChristos Hatzis
Christos Hatzis
WSWeiwei Shi
Weiwei Shi
LPLajos Pusztai
Lajos Pusztai
Introduction: As part of the MicroArray Quality Control (MAQC)-II project, this analysis examines how the choice of univariate feature-selection methods and classification algorithms may influence the performance of genomic predictors under varying degrees of prediction difficulty represented by three clinically relevant endpoints. Methods: We used gene-expression data from 230 breast cancers (grouped into training and independent validation sets), and we examined 40 predictors (five univariate feature-selection methods combined with eight different classifiers) for each of the three endpoints. Their classification performance was estimated on the training set by using two different resampling methods and compared with the accuracy observed in the independent validation set. Results: A ranking of the three classification problems was obtained, and the performance of 120 models was estimated and assessed on an independent validation set. The bootstrapping estimates were closer to the validation performance than were the cross-validation estimates. The required sample size for each endpoint was estimated, and both gene-level and pathway-level analyses were performed on the obtained models. Conclusions: We showed that genomic predictor accuracy is determined largely by an interplay between sample size and classification difficulty. Variations on univariate feature-selection methods and choice of classification algorithm have only a modest impact on predictor performance, and several statistically equally good predictors can be developed for any given classification problem.

12 May 2020 in npj Breast Cancer
Verified
Journal Article
Open access
PDF file
ZKZuzana Kos
Zuzana Kos
ERElvire Roblin
Elvire Roblin
RKRim S. Kim
Rim S. Kim
SMStefan Michiels
Stefan Michiels
BGBrandon D. Gallas
Brandon D. Gallas
RSRoberto Salgado
Roberto Salgado
Stromal tumor-infiltrating lymphocytes (sTILs) are important prognostic and predictive biomarkers in triple-negative (TNBC) and HER2-positive breast cancer. Incorporating sTILs into clinical practice necessitates reproducible assessment. Previously developed standardized scoring guidelines have been widely embraced by the clinical and research communities. We evaluated sources of variability in sTIL assessment by pathologists in three previous sTIL ring studies. We identify common challenges and evaluate impact of discrepancies on outcome estimates in early TNBC using a newly-developed prognostic tool. Discordant sTIL assessment is driven by heterogeneity in lymphocyte distribution. Additional factors include: technical slide-related issues; scoring outside the tumor boundary; tumors with minimal assessable stroma; including lymphocytes associated with other structures; and including other inflammatory cells. Small variations in sTIL assessment modestly alter risk estimation in early TNBC but have the potential to affect treatment selection if cutpoints are employed. Scoring and averaging multiple areas, as well as use of reference images, improve consistency of sTIL evaluation. Moreover, to assist in avoiding the pitfalls identified in this analysis, we developed an educational resource available at www.tilsinbreastcancer.org/pitfalls.

12 May 2020 in npj Breast Cancer
Verified
Journal Article
Open access
PDF file
MAMohamed Amgad
Mohamed Amgad
ESElisabeth Specht Stovgaard
Elisabeth Specht Stovgaard
EBEva Balslev
Eva Balslev
JTJeppe Thagaard
Jeppe Thagaard
WCWeijie Chen
Weijie Chen
LCLee A. D. Cooper
Lee A. D. Cooper
Assessment of tumor-infiltrating lymphocytes (TILs) is increasingly recognized as an integral part of the prognostic workflow in triple-negative (TNBC) and HER2-positive breast cancer, as well as many other solid tumors. This recognition has come about thanks to standardized visual reporting guidelines, which helped to reduce inter-reader variability. Now, there are ripe opportunities to employ computational methods that extract spatio-morphologic predictive features, enabling computer-aided diagnostics. We detail the benefits of computational TILs assessment, the readiness of TILs scoring for computational assessment, and outline considerations for overcoming key barriers to clinical translation in this arena. Specifically, we discuss: 1. ensuring computational workflows closely capture visual guidelines and standards; 2. challenges and thoughts standards for assessment of algorithms including training, preanalytical, analytical, and clinical validation; 3. perspectives on how to realize the potential of machine learning models and to overcome the perceptual and practical limits of visual scoring.

1 September 2003 in Journal of the Optical Society of America A
Verified
Journal Article
Closed access
PDF file
BGBrandon D. Gallas
Brandon D. Gallas
HBHarrison H. Barrett
Harrison H. Barrett
Image quality can be objectively defined according to how well an observer can perform a task of practical interest given the image. We review a practical model observer for the signal-detection task. The ideal observer for this task is a function of the image probability distributions, which are multidimensional and complicated. This observer is often too difficult to derive or estimate. An alternative to the ideal observer is the ideal linear observer, which can still be unmanageable. Our alternative is the ideal linear observer constrained to a small set of channels: the channelized-Hotelling observer.

1 March 2006 in Academic Radiology
Verified
Journal Article
Closed access
BGBrandon D. Gallas
Brandon D. Gallas

1 April 2012 in Academic Radiology
Verified
Journal Article
Closed access
BGBrandon D. Gallas
Brandon D. Gallas
HCHeang-Ping Chan
Heang-Ping Chan
CDCarl J. D’oRsi
Carl J. D’oRsi
LDLori E. Dodd
Lori E. Dodd
MGMaryellen L Giger
Maryellen L Giger
MZMargarita L. Zuley
Margarita L. Zuley